Condition
Epilepsy, Post-Traumatic
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Terminated1
Active Not Recruiting1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT03999164Phase 1Active Not RecruitingPrimary
Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy
NCT05353452Not ApplicableRecruitingPrimary
Collaborative Care in Posttraumatic Epilepsy
NCT00566046Phase 3TerminatedPrimary
Prevention of Post-traumatic Seizures With Levetiracetam
Showing all 3 trials